AKT1 and nonpapillary renal cell carcinoma: To further validate the indirect PI3K and Akt phosphorylation regulation of NOP2 via APOL1, PI3K (LY294002) and Akt (MK-2206) inhibitors were used to inhibit the PI3K/Akt pathway in ccRCC cells overexpressing NOP2.